+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
R

Actively Recruiting

This research aims to collect detailed information on how the Zenflow Spring System, a minimally invasive device treatment, works for men with lower urinary tract symptoms LUTS associated with benign prostatic hyperplasia BPH. The registry tracks the devices performance during the implant procedure and follows participants over time to assess symptom improvement and patient satisfaction. Participants will undergo treatment with the Zenflow Spring System as per the approved instructions for use. The study observes the devices effects during implantation and monitors outcomes through scheduled follow-up visits at 1, 3, 6, and 12 months after the procedure. During the study, participants will have their symptoms, activity recovery, and any side effects or problems related to the device evaluated at these follow-up visits. Researchers will measure effectiveness using the International Prostate Symptom Score IPSS and monitor safety by recording adverse events from baseline through 12 months. The total participation period includes the implantation and one-year follow-up.

Age: 18Years +MALE
8 locations